Case of tinea corporis due to terbinafine-resistant Trichophyton interdigitale. 2020

Maki Kakurai, and Kazutoshi Harada, and Tatsuo Maeda, and Junichiro Hiruma, and Rui Kano, and Toshio Demitsu
Kakurai Dermatology Clinic, Ibaraki, Japan.

UI MeSH Term Description Entries
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003883 Arthrodermataceae A family of ascomycetous fungi, order Onygenales, characterized by smooth ascospores. Genera in the family include Arthroderma, Keratinomyces, and Ctenomyces. Several well-known anamorphic forms are parasitic upon the skin. Arthroderma,Ctenomyces,Dermatophytes,Keratinomyces,Cutaneous Fungi,Cutaneous Fungus,Dermatomyces,Nannizzia,Arthrodermas,Ctenomyce,Dermatomyce,Dermatophyte,Fungi, Cutaneous,Fungus, Cutaneous,Keratinomyce,Nannizzias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077291 Terbinafine A naphthalene derivative that inhibits fungal SQUALENE EPOXIDASE and is used to treat DERMATOMYCOSES of the skin and nails. (E)-N-(6,6-Dimethyl-2-heptenynyl)-N-methyl-1-naphthalenementhamin hydrochloride,DA 5505,Lamisil,SF 86-327,SF-86-327,TDT-067,Terbinafine Hydrochloride,Terbinafine, (Z)-,Terbinafine, (Z)-isomer,SF 86 327,SF 86327,SF86327,TDT 067,TDT067
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D014005 Tinea Fungal infection of keratinized tissues such as hair, skin and nails. The main causative fungi include MICROSPORUM; TRICHOPHYTON; and EPIDERMOPHYTON. Dermatophytoses,Epidermophytosis,Ringworm,Tinea Corporis,Trichophytosis,Dermatophytosis,Trichophyton mentagrophytes Infection,Epidermophytoses,Infection, Trichophyton mentagrophytes,Tineas,Trichophyton mentagrophytes Infections,Trichophytoses
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Maki Kakurai, and Kazutoshi Harada, and Tatsuo Maeda, and Junichiro Hiruma, and Rui Kano, and Toshio Demitsu
April 2019, The Journal of dermatology,
Maki Kakurai, and Kazutoshi Harada, and Tatsuo Maeda, and Junichiro Hiruma, and Rui Kano, and Toshio Demitsu
June 2002, Mycoses,
Maki Kakurai, and Kazutoshi Harada, and Tatsuo Maeda, and Junichiro Hiruma, and Rui Kano, and Toshio Demitsu
October 2012, Mycopathologia,
Maki Kakurai, and Kazutoshi Harada, and Tatsuo Maeda, and Junichiro Hiruma, and Rui Kano, and Toshio Demitsu
July 2021, The Journal of dermatology,
Maki Kakurai, and Kazutoshi Harada, and Tatsuo Maeda, and Junichiro Hiruma, and Rui Kano, and Toshio Demitsu
January 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Maki Kakurai, and Kazutoshi Harada, and Tatsuo Maeda, and Junichiro Hiruma, and Rui Kano, and Toshio Demitsu
November 2023, Dermatologie (Heidelberg, Germany),
Maki Kakurai, and Kazutoshi Harada, and Tatsuo Maeda, and Junichiro Hiruma, and Rui Kano, and Toshio Demitsu
April 2021, The Journal of dermatology,
Maki Kakurai, and Kazutoshi Harada, and Tatsuo Maeda, and Junichiro Hiruma, and Rui Kano, and Toshio Demitsu
January 2013, Indian journal of dermatology, venereology and leprology,
Maki Kakurai, and Kazutoshi Harada, and Tatsuo Maeda, and Junichiro Hiruma, and Rui Kano, and Toshio Demitsu
January 1995, Indian journal of dermatology, venereology and leprology,
Maki Kakurai, and Kazutoshi Harada, and Tatsuo Maeda, and Junichiro Hiruma, and Rui Kano, and Toshio Demitsu
December 2008, Medical mycology,
Copied contents to your clipboard!